Energy Products Inc

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Verrica, Apyx, Waste Management, and Tupperware and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, June 30, 2022
Waste management, FDA, Acquisition, Defendant, SMR, Negotiation, Energy Products Inc, Molluscum contagiosum, Endpoint security, Mergers and acquisitions, Waste Management (corporation), GLOBE, Advanced Energy, Failure, Company, Prospectus, Tupperware, Lists of schools in England, CMO, Disclosure, Food, LLC, Office of Inspector General, U.S. Department of Health and Human Services, NYSE, Coagulation, New Drug Application, U.S. Department of Justice Office of Legislative Affairs, NASDAQ, Tripura Merger Agreement, News, GFL Environmental, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, DOJ, NDA, Tupperware Brands, Pharmaceutical industry, Animal, Renewable energy, Risk management, Audit, Bank, P.C, Note

In November 2021, Verrica resubmitted the NDA for VP-102, claiming [t]he resubmission addresses the successful resolution of inspection deficiencies at the manufacturing facility.

Key Points: 
  • In November 2021, Verrica resubmitted the NDA for VP-102, claiming [t]he resubmission addresses the successful resolution of inspection deficiencies at the manufacturing facility.
  • For more information on the Waste Management class action go to: https://bespc.com/cases/WM
    On May 4, 2022, Tupperware announced its financial results for the first quarter of 2022.
  • For more information on the Tupperware class action go to: https://bespc.com/cases/TUP
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Apyx Medical Corporation (APYX)

Retrieved on: 
Wednesday, June 29, 2022
FDA, Defendant, Energy Products Inc, Court, GLOBE, Advanced Energy, Company, Suite, Lists of schools in England, Food, GPM, NASDAQ, Time, News, Regulation of tobacco by the U.S. Food and Drug Administration, Coagulation, Pharmaceutical industry

LOS ANGELES, June 29, 2022 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (GPM) reminds investors of the upcoming August 5, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Apyx Medical Corporation (Apyx or the Company) (NASDAQ: APYX ) securities between May 12, 2021 and March 11, 2022, inclusive (the Class Period).

Key Points: 
  • LOS ANGELES, June 29, 2022 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (GPM) reminds investors of the upcoming August 5, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Apyx Medical Corporation (Apyx or the Company) (NASDAQ: APYX ) securities between May 12, 2021 and March 11, 2022, inclusive (the Class Period).
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles

APYX MEDICAL CORPORATION (NASDAQ: APYX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Apyx Medical Corporation (NASDAQ: APYX)

Retrieved on: 
Tuesday, June 28, 2022
FDA, Helium, Labour government, Securities Exchange Act of 1934, Energy Products Inc, Court, The Legal 500, Lists of action films, GLOBE, Advanced Energy, Advertising, Company, District court, Lists of schools in England, Food, Investment, NEW, NASDAQ, News, Regulation of tobacco by the U.S. Food and Drug Administration, Coagulation, Tobacco, Pharmaceutical industry, Online gambling, Security (finance)

NEW YORK, June 28, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Apyx Medical Corporation (“Apyx” or the “Company”) (NASDAQ: APYX) between May 12, 2021 and March 11, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Middle District of Florida and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • If so, please visit Apyx Medical Corporation Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • The lawsuit was filed in the United States District Court for the Middle District of Florida and alleges violations of the Securities Exchange Act of 1934.
  • Apyx claims to be an advanced energy technology company with products in the cosmetic and surgical markets.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Apyx Medical Corp. Investors: Company Investigated by the Portnoy Law Firm

Retrieved on: 
Monday, June 27, 2022
Complaint, Review, FDA, Energy Products Inc, GLOBE, Advanced Energy, Company, NASDAQ, News, Coagulation, Life insurance, Pharmaceutical industry

​LOS ANGELES, June 27, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Apyx Medical Corporation (NASDAQ: APYX) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. Apyx investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq.

Key Points: 
  • LOS ANGELES, June 27, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Apyx Medical Corporation (NASDAQ: APYX) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors.
  • Apyx investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq.
  • The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors options for pursuing claims to recover their losses.
  • The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Teladoc, Verrica, Apyx, and Waste Management and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, June 25, 2022
P.C, GLOBE, Growth, Company, Industry, Tax, Food, Office of Inspector General, U.S. Department of Health and Human Services, U.S. Department of Justice Office of Legislative Affairs, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, NDA, Waste management, Teladoc Health, Depreciation, FDA, SMR, EBITDA, Waste Management (corporation), Prospectus, D2C, Walmart, Disclosure, LLC, NYSE, Tripura Merger Agreement, Coagulation, DOJ, Acquisition, Defendant, Energy Products Inc, Molluscum contagiosum, Endpoint security, Mergers and acquisitions, TDOC, Advanced Energy, Failure, New Drug Application, NASDAQ, Amazon (company), News, Mental health, BetterHelp, Negotiation, Lists of schools in England, CMO, GFL Environmental, Risk management, Pharmaceutical industry, Audit, Animal, Bank, Note

Throughout the Class Period, Defendants made materially false and misleading statements regarding the Companys business, operations, and prospects.

Key Points: 
  • Throughout the Class Period, Defendants made materially false and misleading statements regarding the Companys business, operations, and prospects.
  • In the Notes prospectus, Waste Management represented that the Merger would close by the first quarter of 2020.
  • For more information on the Waste Management class action go to: https://bespc.com/cases/WM
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Apyx Medical Corporation - APYX

Retrieved on: 
Thursday, June 23, 2022
GLOBE, FDA, LLP, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, NASDAQ, Food, Company, Coagulation, Energy Products Inc, Advanced Energy, News, Pomerantz, Private investigator

NEW YORK, June 23, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Apyx Medical Corporation (Apyx or the Company) (NASDAQ:APYX).

Key Points: 
  • NEW YORK, June 23, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Apyx Medical Corporation (Apyx or the Company) (NASDAQ:APYX).
  • Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
  • The investigation concerns whether Apyx and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

APYX MEDICAL CORPORATION (NASDAQ: APYX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Apyx Medical Corporation (NASDAQ: APYX)

Retrieved on: 
Wednesday, June 22, 2022
Helium, Securities Exchange Act of 1934, FDA, NEW, Company, Advanced Energy, Regulation of tobacco by the U.S. Food and Drug Administration, Lists of schools in England, Court, The Legal 500, Lists of action films, Labour government, Advertising, Investment, NASDAQ, District court, Energy Products Inc, News, Food, Coagulation, GLOBE, Tobacco, Pharmaceutical industry, Online gambling, Security (finance)

NEW YORK, June 22, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Apyx Medical Corporation (“Apyx” or the “Company”) (NASDAQ: APYX) between May 12, 2021 and March 11, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Middle District of Florida and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • If so, please visit Apyx Medical Corporation Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • The lawsuit was filed in the United States District Court for the Middle District of Florida and alleges violations of the Securities Exchange Act of 1934.
  • Apyx claims to be an advanced energy technology company with products in the cosmetic and surgical markets.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Apyx Medical Corporation (APYX)

Retrieved on: 
Tuesday, June 21, 2022
Time, FDA, Advanced Energy, Regulation of tobacco by the U.S. Food and Drug Administration, Lists of schools in England, Court, Company, Defendant, NASDAQ, Suite, Energy Products Inc, News, Food, Coagulation, GPM, GLOBE, Medical device, Pharmaceutical industry

LOS ANGELES, June 21, 2022 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (GPM) reminds investors of the upcoming August 5, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Apyx Medical Corporation (Apyx or the Company) (NASDAQ: APYX ) securities between May 12, 2021 and March 11, 2022, inclusive (the Class Period).

Key Points: 
  • LOS ANGELES, June 21, 2022 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (GPM) reminds investors of the upcoming August 5, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Apyx Medical Corporation (Apyx or the Company) (NASDAQ: APYX ) securities between May 12, 2021 and March 11, 2022, inclusive (the Class Period).
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Verrica, Apyx, and Waste Management and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, June 20, 2022
FDA, NDA, Advanced Energy, Office of Inspector General, U.S. Department of Health and Human Services, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Lists of schools in England, P.C, Prospectus, Endpoint security, Company, LLC, Waste management, Defendant, GFL Environmental, New Drug Application, Negotiation, Tripura Merger Agreement, Failure, NASDAQ, CMO, Energy Products Inc, News, Acquisition, DOJ, Waste Management (corporation), Molluscum contagiosum, Food, U.S. Department of Justice Office of Legislative Affairs, SMR, Mergers and acquisitions, Coagulation, NYSE, GLOBE, Disclosure, Pharmaceutical industry, Animal, Risk management, Audit, Bank, Note

In November 2021, Verrica resubmitted the NDA for VP-102, claiming [t]he resubmission addresses the successful resolution of inspection deficiencies at the manufacturing facility.

Key Points: 
  • In November 2021, Verrica resubmitted the NDA for VP-102, claiming [t]he resubmission addresses the successful resolution of inspection deficiencies at the manufacturing facility.
  • In the Notes prospectus, Waste Management represented that the Merger would close by the first quarter of 2020.
  • For more information on the Waste Management class action go to: https://bespc.com/cases/WM
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Apyx Medical Corporation Investor News: Robbins LLP is Investigating Apyx Medical Corporation (APYX) on Behalf of Shareholders

Retrieved on: 
Saturday, June 18, 2022
Class Action Lawsuit, Professional Services, Legal, Steps, Complaint, FDA, Company, Coagulation, NASDAQ, Energy Products Inc, News, Advanced Energy, Pharmaceutical industry, Medical device

Shareholder rights law firm Robbins LLP is investigating Apyx Medical Corporation (NASDAQ: APYX) and its officers and directors to determine whether they breached fiduciary duties and violated securities laws by using its products for off-label indications.

Key Points: 
  • Shareholder rights law firm Robbins LLP is investigating Apyx Medical Corporation (NASDAQ: APYX) and its officers and directors to determine whether they breached fiduciary duties and violated securities laws by using its products for off-label indications.
  • Apyx claims to be an advanced energy technology company with products in the cosmetic and surgical markets.
  • If you would like more information about our investigation of Apyx Medical Corporation's misconduct, click here .
  • Next Steps: If you acquired shares of Apyx Medical Corporation securities between May 12, 2021 and March 11, 2022, you have legal options.